Ann Arbor, MI2 Active Studies

Pulmonary Fibrosis Clinical Trials in Ann Arbor, MI

Find 2 actively recruiting pulmonary fibrosis clinical trials in Ann Arbor, MI. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
580
Enrolling

Recruiting Pulmonary Fibrosis Studies in Ann Arbor

About Pulmonary Fibrosis Clinical Trials in Ann Arbor

Pulmonary fibrosis is a condition in which the lung tissue becomes damaged and scarred, making it difficult for the lungs to function properly. Idiopathic pulmonary fibrosis (IPF) is the most common form with unknown cause. Antifibrotic medications can slow progression, and lung transplant may be considered.

There are currently 2 pulmonary fibrosis clinical trials recruiting participants in Ann Arbor, MI. These studies are seeking a combined 580 participants. Research is being sponsored by University of Massachusetts, Worcester, Boehringer Ingelheim. Clinical trial participation is free and participants receive study-related medical care at no cost.

Pulmonary Fibrosis Clinical Trials in Ann Arbor — FAQ

Are there pulmonary fibrosis clinical trials in Ann Arbor?

Yes, there are 2 pulmonary fibrosis clinical trials currently recruiting in Ann Arbor, MI. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Ann Arbor?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Ann Arbor research site will contact you about next steps.

Are clinical trials in Ann Arbor free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Ann Arbor studies also compensate for your time and travel.

What pulmonary fibrosis treatments are being tested?

The 2 active trials in Ann Arbor are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary fibrosis.

Data updated July 19, 2026 from ClinicalTrials.gov